Pluripotency factor binding and Tsix expression act synergistically to repress Xist in undifferentiated embryonic stem cells by Nesterova, Tatyana B et al.
RESEARCH Open Access
Pluripotency factor binding and Tsix expression
act synergistically to repress Xist in
undifferentiated embryonic stem cells
Tatyana B Nesterova
1†, Claire E Senner
1,2†, Janina Schneider
1,3, Tilly Alcayna-Stevens
1, Anna Tattermusch
1,
Myriam Hemberger
2 and Neil Brockdorff
1*
Abstract
Background: Expression of Xist, the master regulator of X chromosome inactivation, is extinguished in pluripotent
cells, a process that has been linked to programmed X chromosome reactivation. The key pluripotency transcription
factors Nanog, Oct4 and Sox2 are implicated in Xist gene extinction, at least in part through binding to an element
located in Xist intron 1. Other pathways, notably repression by the antisense RNA Tsix, may also be involved.
Results: Here we employ a transgene strategy to test the role of the intron 1 element and Tsix in repressing Xist in
ES cells. We find that deletion of the intron 1 element causes a small increase in Xist expression and that
simultaneous deletion of the antisense regulator Tsix enhances this effect.
Conclusion: We conclude that Tsix and pluripotency factors act synergistically to repress Xist in undifferentiated
embryonic stem cells. Double mutants do not exhibit maximal levels of Xist expression, indicating that other
pathways also play a role.
Background
In female mammals a developmentally regulated process,
X inactivation, ensures silencing of a single X chromo-
some, balancing levels of X-linked genes relative to males
[1]. X inactivation is mediated by the cis-acting non-cod-
ing RNA Xist that is transcribed from and coats the inac-
tive X chromosome (Xi) elect [2]. Coating by Xist RNA
triggers epigenetic modifications that silence transcription
and establish a heritable heterochromatic state [3].
X inactivation in the mouse occurs in two waves;
imprinted X inactivation of the paternal X chromosome
(Xp) that is initiated in two to four cell embryos and
maintained in all cells until the blastocyst stage, and ran-
dom X inactivation, initiated in the postimplantation epi-
blast. Embryo precursors in the inner cell mass (ICM) of
the blastocyst reactivate Xp, reversing imprinted X inacti-
vation and setting the ground state for the onset of ran-
dom X inactivation [4,5]. XX embryonic stem (ES) cells,
which are derived from the ICM, mirror this ground
state, retaining two active X chromosomes [6,7]. In con-
trast extraembryonic trophectoderm and primitive endo-
derm lineages and cell lines derived thereof retain the
imprinted X inactivation pattern through embryogenesis
[8-11].
X chromosome reactivation also occurs in XX primor-
dial germ cells during migration towards the genital
ridges [12-14], and similarly during experimental repro-
gramming of XX somatic cells, either by cloning, cell
fusion with pluripotent cells or induced pluripotent
stem cell technology [15-17]. In all of these examples,
including ICM cells, X reactivation is linked to extinc-
tion of Xist RNA expression from Xi. Xist-dependent
reversibility of X inactivation is specific to pluripotent
lineages and/or cell types as conditional knockout of
Xist in somatic cells does not lead to X reactivation
[18,19].
The mechanism underlying extinction of Xist expres-
sion in pluripotent cells is poorly understood. The anti-
sense repressor Tsix is a candidate but deletion of the
Tsix promoter in undifferentiated ES cells leads to only
low levels of Xist upregulation and in a small proportion
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in primordial germ cells (PGCs) at the time of X reactiva-
tion [13]. A second candidate is a Nanog/Oct4/Sox2
(NOS)-binding element located in Xist intron 1 [22].
Depletion of Nanog or Oct4 does indeed increase levels
of Xist RNA. Set against this, a recent study found that
deletion of the intron 1 NOS does not increase Xist RNA
levels in undifferentiated XX ES cells, although there was
an effect on X chromosome choice following differentia-
tion in vitro [23]. In this study we have used a transgenic
strategy to analyse the role of the intron 1 NOS and Tsix
in repressing Xist in ES cells. We show that deletion of
the intron 1 element moderately increases Xist expres-
sion in ES cells and that this effect is amplified by simul-
taneous deletion of Tsix.W ec o n c l u d et h a tTsix and the
intron 1 NOS function synergistically to repress Xist in
undifferentiated ES cells.
Results and Discussion
Repositioning and inversion of the intron 1 NOS does not
affect Xist regulation
A previous study demonstrated that acute downregula-
tion of Oct4 in XY ES cells leads to rapid depletion of
Oct4, Nanog and Sox2 proteins at the binding region of
Xist intron 1 and considerable upregulation of Xist
expression [22]. This effect, however, is observed only in
10% of cells and is accompanied by cell differentiation.
To exclude the possibility of an indirect effect of Oct4/
Nanog depletion on Xist regulation, we decided to
directly test the role of NOS binding sites within Xist
intron 1. For initial analysis we took advantage of a pre-
viously generated XY ES cell line (NBXT INV1) carrying
a targeted inversion between exon 1 and intron 4 of the
Xist locus [24]. In this cell line, the intron 1 element is
retained but in a different position and in a reversed
orientation (Figure 1A). We first analysed by RNA fluor-
escent in situ hybridisation (FISH) if Xist remained
repressed in these cells. We found the culture to be indis-
tinguishable from its parental wild-type counterpart (129/
1), with one punctate signal in each cell (Figure 1B). As
Xist remained repressed in these cells we then carried
out chromatin immunoprecipitation (ChIP) to determine
if Xist repression was maintained in the presence or
absence of Nanog binding to intron 1 (Figure 1C). Again
we found NBXT INV1 and 129/1 to be indistinguishable,
with Nanog binding occurring at the Oct4 proximal pro-
moter and Xist intron 1 to the same extent in both cell
lines. As expected, Nanog binding was not detected in
t h ee x t r a e m b r y o n i ce n d o d e r m( X E N )c e l ll i n ew h e r e
Nanog is not expressed ([8] and our unpublished data).
Thus, it appears that reversing the orientation of the
binding site in Xist intron 1 does not interfere with either
Nanog binding or regulation of Xist expression.
Deletion of Xist intron 1 within a P1 construct triggers
Xist upregulation
Since inversion of Xist intron 1 did not disrupt its pur-
ported function we decided to delete the region by
Galactokinase (GalK)-mediated recombineering [25] in a
P1-derived artificial chromosome carrying the entire
Xist genomic sequence plus 34.2 kb upstream of the
Xist transcriptional start site (TSS) and 24 kb down-
stream of Xist exon 8, and therefore encompassing most
of the known critical Xist cis regulatory elements. As a
positive control we analysed ES cells transfected with
the P1 construct with an inducible promoter (tetracy-
cline responsive element;T R E )i n t r o d u c e da tt h eXist
TSS. Addition of doxycycline caused a robust Xist tran-
scription and accompanying chromosomal acquisition of
histone modifications associated with the silenced state
(Additional file 1).
A bioinformatic search for NOS consensus sequences
within the Xist locus revealed three potential Nanog-bind-
ing sites and one Oct4/Sox2-binding site located in close
proximity to each other within intron 1 (data not shown).
The identified sites lay within the region that showed the
highest enrichment for Nanog and Oct4 proteins ([22]
and our unpublished data). Based on this data we designed
a strategy to remove the minimal region encompassing
these sites in the P1 clone. The homology arms for recom-
bineering were designed to delete 0.3 kb of the intron 1
region without introducing any foreign sequences (Figure
2A; see Methods). The resulting construct Δint0.3 as well
as the parental P1 clone (wild type; wt) were co-lipofected
with a selection plasmid carrying puromycin resistance
under the control of mammalian Phosphoglycerate kinase
promoter (pPGKpuro) into the 129/1 XY ES cell line and
puromycin-resistant colonies were picked and analysed by
PCR for the presence of a P1 construct. Twelve P1-posi-
tive clones for each construct were selected randomly for
analysis of Xist expression.
RNA FISH analysis of Xist and Tsix transcripts
showed an upregulated Xist domain is present in a pro-
portion of cells in the majority of the clones carrying
Δint0.3 (Figure 3A). The proportion of Xist domains
varied considerably between different clones (0% to
69%) and the size and appearance of the domains varied
between clones as well as between cells of the same
clone (Figure 2A, 3A). Generally, domains were smaller
than those observed in female somatic cells, but in some
cells they were diffuse and occupied a large area of the
nucleus. In contrast, all but one clone with the control
wt P1 construct showed one or two punctate signals,
corresponding to the endogenous and transgenic Xist
(Figure 2B, 3A). The single exception, clone D6, showed
a domain reminiscent of Xist in female somatic cells.
However, an equivalent signal was detected with both
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Page 2 of 10Figure 1 Analysis of Nanog binding to Xist Intron 1 in ES cells carrying a targeted inversion in Xist. (A) Schematic representation of the
wt and INV Xist alleles. Arrows indicate the position of the NOS binding site. (B) RNA FISH images showing Xist (green) and Tsix (red) expression
in wt ES cells (129/1) and those carrying a targeted inversion in the Xist locus (NBXT INV1). Arrowheads point to punctate signal. DNA was
counterstained with DAPI (blue). (C) Occupancy of the Oct4 promoter and Xist intron 1 by Nanog in wt ES cells (129/1) and NBXT INV1. XEN cells
which do not express Nanog were used as a negative control. The promoter of the housekeeping gene B2M was used as a negative control for
Nanog binding. DAPI: 4’,6-diamidino-2-phenylindole; ES: embryonic stem; FISH: fluorescent in situ hybridisation; NBXT INV1: Xist allele carrying a
targeted inversion; wt: wild type; XEN: extraembryonic endoderm.
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Page 3 of 10Figure 2 Deletion of NOS binding region within Xist intron 1 causes moderate upregulation of transgenic Xist expression in
undifferentiated XY ES cell lines. (A) schematic representation of X inactivation centre region cloned into bacteriophage clone P1. Xist and
Tsix exons are indicated as black and grey rectangles, respectively. The first three exons of Enox/Jpx are also shown. The direction of transcription
for each locus is indicated by arrows. An enlarged region spanning Xist exons 1 to 3 is shown underneath the main schematic. Blue horizontal
bars underneath indicate the position of homology arms used for recombineering. 0.3 kb (Δint0.3) and 2.1 kb (Δint2.1) sequences within intron 1
deleted from P1 clone by recombineering both encompass NOS-binding region. Blue lines above the main schematic indicate the position of
the homology arms and the deleted region of the Tsix promoter (ΔCpG). (B) RNA FISH analysis of Xist and Tsix expression in undifferentiated XY
ES clones carrying wt P1 construct (clone L5E2), P1 construct with small (Δint0.3, clone L9D7) or large deletion (Δint2.1, clone L7B2). Bar, 10 μm.
(C) A graph showing proportional representation of four patterns of Xist expression in XY ES clones carrying P1 transgenes: light grey, no
detectable Xist expression; red, upregulated Xist cloud; grey, two punctate Xist signals; dark grey, one punctate Xist signal. Average data for 12
clones of each genotype are shown. Individual clone data are shown in Figure 3A. (D) Graph showing a percentage of clones with upregulated
Xist. (E) qRT-PCR analysis of Xist expression in XY ES clones carrying either wt P1 or P1 with 0.3 kb (Δint0.3) or 2.1 kb (Δint2.1) deletions in Xist
intron 1. All data is normalised to b-actin transcript levels and presented relative to the wt XY ES (129/1) Xist RNA level. Average data for 12
clones of each genotype are shown. Individual clone data are shown in Figure 3B. ES: embryonic stem; FISH: fluorescent in situ hybridisation;
NOS: Nanog/Oct4/Sox2; qRT-PCR: quantitative reverse transcription polymerase chain reaction; wt: wild type.
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Page 4 of 10Xist and Tsix probes (Additional file 2), suggesting that
the P1 transgene integrated in multicopy in an open
chromatin environment, leading to misexpression of
both Xist and Tsix loci. This clone was therefore
excluded from further analysis. Together, these results
indicate that deletion of the NOS binding region leads
to moderate upregulation of Xist expression in undiffer-
entiated ES cells.
Figure 3 Deletion of Xist intron 1 and the Tsix promoter causes upregulation of transgenic Xist expression in undifferentiated XY ES
cell lines. (A) Graphs showing proportional representation of four patterns of Xist expression in XY ES clones carrying P1 transgenes: light grey,
no detectable Xist expression; red, upregulated Xist cloud; grey, two punctate Xist signals; dark grey, one punctate Xist signal. Each bar
represents an individual clone. (B) qRT-PCR analysis of Xist expression in XY ES clones carrying P1 transgenes. All data is normalised to b-actin
transcript levels and presented relative to the wt XY ES (129/1) Xist RNA level. Each bar represents an individual clone. ES: embryonic stem; qRT-
PCR: quantitative reverse transcription polymerase chain reaction; wt: wild type.
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Page 5 of 10Our bioinformatic analysis revealed several other bind-
ing sites for Nanog, Oct4 and Sox2 spread throughout
Xist intron 1. We decided to extend the deletion and
remove 2.1 kb of intron 1 (Δint2.1) to test whether
these other sites contribute to the repression of Xist
(Figure 2A). RNA FISH analysis of a series of clones
yielded results similar to those obtained for Δint0.3
(Figure 2B, C, Figure 3A). Once again, the degree of
Xist upregulation varied between clones (0% to 76%)
and the Xist domains observed were similar to those in
Δint0.3 clones. This result indicated that the repressive
function of intron 1 maps predominantly to the 0.3 kb
minimal binding region.
We went on to analyse the degree of Xist upregulation
by quantitative RT-PCR (qRT-PCR). As expected, clones
that showed Xist domains by RNA FISH analysis also
showed higher levels of Xist expression (Figure 3B).
Further, our RT-PCR analysis of Xist exon-intron struc-
ture demonstrated that Xist RNA was spliced correctly
(data not shown). On average, Xist was upregulated
approximately four times over the level of Xist in P1 wt ES
cells for both Δint0.3 and Δint2.1 (Figure 2E). Taking into
account that only 50% to 60% of clones had demonstrated
a substantial proportion of cells with an Xist domain (Fig-
ure 2D), the degree of Xist upregulation in clones with the
domain was considerably higher (Figure 3B). Thus dele-
tion of the binding region for Nanog, Oct4 and Sox2
located within the Xist intron 1 caused derepression of
Xist, albeit to varying degrees between and within different
clones.
Simultaneous deletion of Xist intron 1 and the Tsix
promoter facilitates derepression of Xist expression
The non-coding RNA Tsix is transcribed in an antisense
orientation through the entire Xist locus and is regarded
as a major repressor of Xist in undifferentiated ES cells
[26]. However, a deletion of the Tsix promoter or prema-
ture termination of the Tsix transcript causes only lim-
ited Xist upregulation [20,21]. We hypothesised that Tsix
and Xist intron 1 may function redundantly in repressing
Xist in undifferentiated ES cells. To test this, a deletion of
the Tsix promoter and the major transcriptional start site
(ΔCpG) [26] was introduced by recombineering into the
control P1 construct (ΔCpG) and in the P1 construct car-
rying the large intron 1 deletion (Δint2.1ΔCpG).
Twelve clones carrying each P1 construct were analysed
by RNA FISH for the presence of an Xist domain. Several
ΔCpG clones had 1% to 10% of cells with a small Xist
cluster, consistent with previous observations using Tsix
mutant ES cells [21]. Two clones showed somewhat higher
numbers of cells with a small Xist domain (23% and 36%),
which was probably due to the site of integration or copy
number (Figure 3A). Around half of the Δint2.1ΔCpG
clones had an Xist accumulated domain, a result similar to
Δint2.1 alone. However, the accumulated domain was gen-
erally larger in the clones that showed upregulation and
the overall proportion of cells with the domain within
those clones was higher (Figure 4A-C). qRT-PCR analysis
confirmed the latter observation as average Xist expression
w a sm o r et h a nt w o - f o l dh i g h e ri nΔint2.1ΔCpG compared
with Δint2.1 or ΔCpG alone (Figure 3B, 4D).
While the results of these experiments clearly indicated
that Xist intron 1 and Tsix contribute synergistically to
the repression of Xist in undifferentiated ES cells, there
was considerable variability of Xist derepression between
different clones. A relatively high proportion of clones
and/or cells carrying P1 with single or double deletions
did not exhibit an Xist domain in spite of initial positive
genotyping for the presence of a P1 transgene. There are
several possible causes for this variability, namely copy
number of the transgene, site of integration, orientation
of transgenic copies and transgene instability. Using
qPCR and Southern blot hybridisation we estimated copy
number of Xist transgenes to vary between one and four-
teen. There is a general correlation, in that clones with
higher transgene copy numbers are more likely to show
some degree of Xist upregulation. However, this is not
absolute and some clones with just two copies of the
transgene show much higher upregulation than clones
with higher copy number.
Southern blot analysis revealed that the majority of
clones have rearrangements, indicating transgene
instability (Additional file 3). We reasoned that since the
clonal analysis requires prolonged passaging of cells in
culture, this could enhance frequency of transgene rear-
rangements due to selective pressure or/and transgene
instability over time. To minimize this effect, we decided
to use a different approach and analyse pooled clones
after co-lipofection of P1 transgene with a pPGKpuro
selective plasmid immediately after they have undergone
a selection for transgene integration. This approach has
the disadvantage that not every clone will contain a P1
construct, but assuming that all parameters are the same,
pools with different P1 constructs will have similar lipo-
fection efficiency and average transgene copy number.
We performed the experiment on three different pools
for each construct to account for experimental variability.
Initially we analysed each pool individually by Southern
blot hybridisation analysis to determine the average copy
number and assess transgene integrity. As anticipated,
pooled clones with minimal passaging time did not show
any transgene rearrangements (Figure 5A). Transgene
copy number varied between the experiments, but was
broadly similar between the different pools within each
experiment (Figure 5A).
RNA FISH analysis of the pooled clones confirmed the
data from the analysis of individual clones, and pools
carrying Δint2.1ΔCpG showed the highest proportion of
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Page 6 of 10cells with an Xist domain (not shown). To quantify this
we analysed Xist upregulation in clone pools by qRT-
PCR. Average data were obtained for three primer pairs
along the Xist transcript (ex1, ex2-3 and ex4-5) for each
of the pools. We observed variability in the degree of
Xist upregulation between the experiments, however
pools with Δint2.1ΔCpG consistently showed the highest
Xist expression level (Figure 5B).
Taken together, our results suggest that the Xist intron
1r e g i o ni si m p o r t a n tf o rXist repression in undifferen-
tiated pluripotent cells, as proposed previously [22], but
that it functions synergistically with Tsix,t h et w o
mechanisms acting redundantly. The latter finding may
provide some explanation for the observations of Barakat
and colleagues [23], who did not detect Xist upregulation
in undifferentiated XX ES cells carrying deletion of the
intron 1 NOS on one allele. Our data show that the
intron 1 NOS behaves as a classical silencer element in
that it can function in a distance and orientation inde-
pendent manner.
Whilst our results provide clear evidence supporting a
role of the intron 1 NOS in Xist repression, the Xist upre-
gulation we observed from mutant transgenes is relatively
variable, both between clones and within individual
clones, and rarely occurs to the extent seen in XX
somatic cells. It is possible that this variability and low
expression is a consequence of selection against the cells
which upregulate Xist and silence autosomal genes in cis,
although arguing against this we did not observe
increased lethality in clones with high transgenic Xist
expression. A more plausible explanation is that other
repressors and/or Xist activators play a role. Sado and
colleagues [27] observed significant upregulation of the
Xist promoter in ES cells carrying a deletion of a large
region including much of Xist exon 1 and some of Xist
intron 1. Whilst it is possible that this deletion disrupts
Figure 4 Simultaneous deletion of the Tsix CpG island and Xist intron 1 further increases transgenic Xist activation in undifferentiated
XY ES cell lines. (A) RNA FISH analysis of Xist and Tsix expression in undifferentiated XY ES clones carrying P1 construct with deletion of the Tsix
promoter (ΔCpG) and Xist intron 1 (Δint2.1, clone L8F1). (B) Graph showing proportional representation of four patterns of Xist expression in XY
ES clones carrying P1 transgenes. Average data for 12 clones of each genotype are shown. Individual clone data are shown in Figure 3A. (C) A
graph showing the percentage of clones with upregulated Xist. (D) qRT-PCR analysis of Xist expression in XY ES clones carrying either wt P1, P1
with deletion of Tsix promoter (ΔCpG), P1 with 2.1 kb (Δint2.1) deletion in Xist intron 1 or simultaneous deletion of Tsix promoter (ΔCpG) and Xist
intron 1 (Δint2.1). All data is normalised to b-actin transcript levels and presented relative to the wt XY ES (129/1) Xist RNA level. Average data
for 12 clones of each genotype are shown. Individual clone data are shown in Figure 3B. See Figure 2 for detailed annotation. ES: embryonic
stem; FISH: fluorescent in situ hybridisation; qRT-PCR: quantitative reverse transcription polymerase chain reaction; wt: wild type.
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also possible that other unidentified functional sequences
have been removed. Also relevant is that synergistic func-
tion of the intron 1 NOS and Tsix cannot account for
Xist repression in PGCs as Tsix appears not to be
expressed in this context [13,14], again suggesting that
other factors can contribute. Finally, it is not known the
degree to which levels of Xist activators, for example
Rnf12 [23,28] or the Jpx/Enox ncRNA [29] could contri-
bute to reduced Xist expression in pluripotent cells. A
recent study indicates that pluripotency factors repress
levels of Rnf12 [30], although set against this, ectopic
expression of Rnf12 in ES cells with the intron 1 NOS
deletion does not trigger Xist upregulation [23].
Conclusion
Our results show that Xist repression in undifferentiated
ES cells is controlled by synergistic and/or redundant
mechanisms. Binding of pluripotency factors to the ele-
ment in Xist intron 1 contribute to Xist repression, as
does transcription of the antisense RNA, Tsix. However,
ablation of these two pathways does not lead to com-
plete derepression, indicating that other pathways must
also be involved.
Methods
Cell culture
The 129/1 ES cell line [31] was grown as previously
described [32]. ES cells were lipofected with P1 DNA
using Lipofectamine 2000 (Invitrogen, UK) according to
the manufacturer’s instructions. The night before transfec-
tion, 1 × 10
6 cells were seeded in antibiotic-free medium
on a well of a six-well plate. The cells were co-lipofected
with 2 μg of P1 DNA and 50 ng of selective plasmid with
the puromycin resistance gene under the PGK promoter
with a 1:3 ratio between DNA and Lipofectamine 2000.
The cells were trypsinised 24 h later and replated on a 90
mm Petri dish seeded with puromycin-resistant mitomycin
(Sigma-Aldrich, UK)-inactivated feeder cells. Puromycin
selection (2 μg/mL) was applied 48 h after lipofection.
Puromycin-resistant colonies were either picked individu-
ally and expanded for analysis 12 days later or all colonies
were pooled together and analysed 11 days after
transfection.
The XEN16 cell line derived in house was cultured in
Royal Park Memorial Institute (RPMI) 1640 medium sup-
plemented with 10% FCS, 100 units/mL penicillin, 100 μg/
mL streptomycin, 2 mM L-glutamine, 1 mM sodium pyru-
vate and 50 μM b-mercaptoethanol (all reagents from
Invitrogen unless otherwise stated). This cell line was used
as a negative control for ChIP with Nanog antibody
(Cosmo Bio Co., Ltd, Japan) as XEN cells do not express
Nanog.
Recombineering
GalK-mediated recombineering in the P1 15503 (Incyte
Genomics, USA) clone was performed essentially as pre-
viously described [25]. Arms of homology for each of the
recombineering constructs were cloned into the pBlue-
script plasmid and the GalK gene was inserted in
between. These GalK-carrying plasmids were used for
the first round of recombineering to replace a region of
interest with the GalK selective gene. pBluescipt plasmids
with arms of homology only were used for the second
round of recombineering to remove GalK.P r i m e r su s e d
for PCR to amplify the arms of homology are listed in
Additional file 4.
RT-PCR analysis
RNA was isolated using TRIZOL reagent (Invitrogen) and
treated with Turbo DNA-free reagent (Applied Biosys-
tems, UK) according to the manufacturer’si n s t r u c t i o n s .
cDNA synthesis was primed from random hexamers (GE
Healthcare, Life Sciences, UK) with Superscript III reverse
transcriptase (Invitrogen). qRT-PCR was performed with
Figure 5 Analysis of Xist expression in lipofected cell pools. (A)
Southern blot analysis of DNA extracted from the cell pools 12 days
after lipofection of P1 transgenes into undifferentiated XY ES cells.
Data for two experiments are shown. (B) qRT-PCR analysis of Xist
expression in XY ES cell pools transfected with P1 transgenes. All
data is normalised to b-actin and wt Xist transcript level in XY ES
cells (129/1). The average value from three independent
experiments (+ SEM) is shown for each transgenic genotype. ES:
embryonic stem; Msx: homeobox, msh-like 1 autosomal gene used
for internal normalisation; qRT-PCR: quantitative reverse transcription
polymerase chain reaction; R: Raoul marker; wt: wild type.
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on a Chromo4 Real-time PCR System (BioRad Labora-
tories). PCR primers and conditions were as described pre-
viously [33]. The data was normalised to b-actin and then
to the 129/1 control ES cell line.
RNA FISH analysis
RNA FISH was performed essentially as described pre-
viously [34]. pXist, an 18 kb DNA fragment spanning the
whole Xist transcript, was directly labelled using Spec-
trum Green-dUTP and nick translation kit (both from
Abbott Diagnostics, Abbot UK). A Spectrum Red-dUTP
(Abbott Diagnostics)-directly labelled 2.5 kb PCR frag-
ment from the region immediately downstream from the
ΔCpG deletion was used as a Tsix probe. Images were
acquired on a Zeiss AX10 microscope equipped with
AxioCam MRm charge-coupled device camera using
AxioVision software (Carl Zeiss International, UK).
Immunofluorescence
ES cells were trypsinised, rinsed with EC10 medium fol-
lowed by a PBS wash and cytospun onto Superfrost Plus
glass slides (VWR, UK) at 1800 rpm for 3 min (Cytospin
centrifuge; Shandon, Pittsburgh). Immunofluorescence
was then performed as described previously [35].
Chromatin immunoprecipitation
Cells were trypsinised, washed with ice-cold PBS and fixed
in 1% formaldehyde in PBS for 10 min at room tempera-
ture with constant rotation. The crosslinking reaction was
q u e n c h e db yt h ea d d i t i o no f1 / 1 0v o l u m eo f1 . 2 5Mg l y -
cine. After washing in ice-cold PBS, the cells were lysed in
ChIP lysis buffer (50 mM Tris, pH 8.0; 10 mM EDTA; 1%
SDS), containing protease inhibitors (Complete mini,
Roche Diagnostic, UK). The lysates were sonicated using a
Bioruptor sonicator (Diagenode, Belgium) to yield frag-
ment sizes between 300 and 500 bp and stored at -80°C
until immunoprecipitation was carried out. The lysate
containing the chromatin was diluted 1:10 in dilution buf-
fer (1% Triton X-100, 2 mM EDTA pH8.0, 150 mM NaCl,
20 mM Tris-HCl pH 8, protease inhibitors). 75 μgc h r o -
matin was then incubated with 4 μg antibody (anti-Nanog,
Cosmo Bio; anti-Oct4 sc-8628X, Santa Cruz; immunoglo-
bulin G, Abcam, UK or Sigma-Aldrich) overnight at 4°C
and then with protein G agarose beads pre-blocked with
salmon sperm DNA (Millipore (UK) Ltd) for 3 h at 4°C.
The beads were washed four times in low salt wash buffer
(0.1% SDS, 1% Triton X-100, 2 mM EDTA, 150 mM
NaCl, 20 mM Tris-HCl pH 8, protease inhibitors) and
once in high salt wash buffer (0.1% SDS, 1% Triton X-100,
2 mM EDTA, 500 mM NaCl, 20 mM Tris-HCl pH 8, pro-
tease inhibitors). Immunoprecipitated DNA was eluted
from the beads by incubation in elution buffer (1% SDS,
0.1 M sodium bicarbonate) with 150 μg proteinase K and
50 μg RNaseA for 2 h at 37°C and overnight at 65°C. DNA
was then isolated by standard phenol:chloroform extrac-
tion. qPCR analysis of isolated DNA was performed on
Chromo4 Real-time PCR System (BioRad Laboratories)
using primers and conditions listed in Additional File 4.
Additional material
Additional file 1: An inducible P1 Xist transgene triggers repressive
histone tail modifications upon induction with doxycycline. (A)
Schematic representation of XIC region cloned into bacteriophage clone
P1 15503 (P1). Relative positions of Xist gene (blue rectangle), Tsix
promoter and TSS (dark grey box and arrow) and TRE (red box and
arrow) are shown. Arrows indicate the direction of transcription. (B) RNA
FISH analysis of Xist expression (green) in an undifferentiated XY ES line
carrying an inducible P1 Xist transgene before (-dox) and after 1 day
(+dox) of treatment with doxycycline. (C) Representative examples of
H3K27me3 and H2AK119u1 staining of an undifferentiated XY ES line
carrying an inducible P1 Xist transgene after one day of treatment with
doxycycline.
Additional file 2: Xist upregulation in the wt P1 clone D6 is caused
by a different mechanism. Representative examples of cells from P1 wt
D6, P1 Δint2.1 B2 and P1 Δint2.1 ΔCpG F1 clones are shown. Note the
presence of large upregulated Tsix domain co-localising with
upregulated Xist domain in P1 wt D6 and absence of Tsix domain in the
P1 deletion mutant clones. Green arrows point to the Xist domain and
red arrows indicate the corresponding position the red channel (Tsix
probe). Directly labelled full length Xist cDNA (Xist, Spectrum Green,
Abbott Diagnostics) and 2.6 kb Tsix fragment non-overlapping with the
ΔCpG deletion (Tsix, Spectrum Red, Abbott Diagnostics; 29.8 kb
downstream from the Xist TSS) were used as probes.
Additional file 3: Analysis of Xist expression in P1 transgenic clones.
Representative examples of Southern blot analysis of genomic DNA
extracted from the ES clones lipofected with P1 transgenes. Genotype of
P1 clone used for lipofection is indicated above the blots. R, Raoul
marker (MP Biomedicals UK); Msx, homeobox, msh-like 1 autosomal gene
used for internal normalisation.
Additional file 4: Supplemental table 1. File contains a list of primers
and PCR conditions used for ChIP analysis and to amplify arms of
homology in P1 recombineering assay.
Abbreviations
ChIP: chromatin immunoprecipitation; EDTA: ethylenediaminetetraacetic acid;
ES: embryonic stem; FCS: foetal calf serum; FISH: fluorescent in situ
hybridisation; GalK: galactokinase; ICM: inner cell mass; NOS: Nanog/Oct4/
Sox2; PBS: phosphate buffered saline; PCR: polymerase chain reaction; PGC:
primordial germ cell; PGK: phosphoglycerate kinase; qRT-PCR: quantitative
reverse transcription PCR; RT: reverse transcription; TSS: transcriptional start
site; wt: wild type; XEN: extraembryonic endoderm; Xist: X inactive specific
transcript; Xi: inactive X chromosome; Xp: paternal X chromosome.
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